Curran Simpson

Curran Simpson

Directeur Général chez REGENXBIO INC.

Fortune : 321 128 $ au 31/05/2026

64 ans
Health Technology
Consumer Services
Process Industries

Profil

Curran M.
Simpson
currently works at REGENXBIO, Inc., as President, Chief Executive Officer & Director from 2024 and Alliance for Regenerative Medicine, as Director.
Mr. Simpson also formerly worked at Biogen MA, Inc., as Director-Manufacturing Sciences from 2001 to 2003, Covance Biotechnology Services, Inc., as Engineering Director from 1999 to 2001, Genentech, Inc., as Senior Research Engineer from 1992 to 1995, Nalco Chemical Co., as Senior Chemist from 1985 to 1987, Genencor International, Inc., as Senior Scientist-Development from 1987 to 1992, GSK Plc, as COO & Head-North American Supply Chain from 2012 to 2015, Novo-Nordisk Biochem, Inc., as Manager-Pilot Plant North America Division from 1995 to 1997, and Human Genome Sciences, Inc., as Senior Vice President-Operations from 2006 to 2012.
Mr. Simpson received his undergraduate degree from Clarkson College and graduate degree from Clarkson University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/04/2026 45 810 ( 0,09 % ) 321 128 $ 31/05/2026

Postes actifs de Curran Simpson

SociétésPosteDébut
REGENXBIO INC. Directeur Général 01/07/2024
Directeur/Membre du Conseil -

Anciens postes connus de Curran Simpson

SociétésPosteFin
GSK PLC Directeur des opérations 01/08/2015
Directeur des opérations 01/12/2012
Corporate Officer/Principal 01/01/2003
Corporate Officer/Principal 01/01/2001
Novo-Nordisk Biochem, Inc.
Corporate Officer/Principal 01/01/1997
Voir l'expérience en détail de Curran Simpson

Formation de Curran Simpson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Novo-Nordisk Biochem, Inc.

Health Services

  1. Bourse
  2. Insiders
  3. Curran Simpson
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇